Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: BRN024
MIFTS: 67

Bronchitis

Categories: Respiratory diseases
Genes Tissues Related diseases Publications Pathways Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Bronchitis

About this section

MalaCards integrated aliases for Bronchitis:

Name: Bronchitis 12 3 3 44 15 63 73
Chronic Bronchitis 12 76 29 43 15
Acute Bronchitis 12 43 63 73
Bronchitis, Chronic 76 44 73
Chest Cold 12 3
Acute Lower Respiratory Tract Infection 73
Acute Bronchitis and Bronchiolitis 12
Lower Respiratory Tract Infection 73
Recurrent Wheezy Bronchitis 12
Ci - Chest Infection 12
Bronchitis Chronic 55
Chest Infection 12

Classifications:

MalaCards categories:
Anatomical: Respiratory diseases
See all MalaCards categories (disease lists)
ICD10: 33


Sources

Summaries for Bronchitis

About this section
MedlinePlus : 43 Bronchitis is an inflammation of the bronchial tubes, the airways that carry air to your lungs. It causes a cough that often brings up mucus. It can also cause shortness of breath, wheezing, a low fever, and chest tightness. There are two main types of bronchitis: acute and chronic. Most cases of acute bronchitis get better within several days. But your cough can last for several weeks after the infection is gone. The same viruses that cause colds and the flu often cause acute bronchitis. These viruses spread through the air when people cough, or though physical contact (for example, on unwashed hands). Being exposed to tobacco smoke, air pollution, dusts, vapors, and fumes can also cause acute bronchitis. Less often, bacteria can also cause acute bronchitis. To diagnose acute bronchitis, your health care provider will ask about your symptoms and listen to your breathing. You may also have other tests. Treatments include rest, fluids, and aspirin (for adults) or acetaminophen to treat fever. A humidifier or steam can also help. You may need inhaled medicine to open your airways if you are wheezing. Antibiotics won't help if the cause is viral. You may get antibiotics if the cause is bacterial. NIH: National Heart, Lung, and Blood Institute

MalaCards based summary : Bronchitis, also known as chronic bronchitis, is related to bronchial disease and pulmonary disease, chronic obstructive, and has symptoms including cough, shortness of breath and chest tightness. An important gene associated with Bronchitis is ELANE (Elastase, Neutrophil Expressed), and among its related pathways/superpathways are Innate Immune System and Allograft rejection. The drugs Augmentin and Avelox I.V. have been mentioned in the context of this disorder. Affiliated tissues include lung, testes and skin, and related phenotypes are hematopoietic system and immune system

Disease Ontology : 12 A bronchial disease that is an inflammation of the bronchial tubes. It is caused by bacteria and viruses. The disease has symptom cough with mucus, has symptom shortness of breath, has symptom low fever and has symptom chest tightness.

CDC : 3 Español: Bronquitis

PubMed Health : 63 About acute bronchitis: In acute bronchitis, the lower airways (bronchi) are temporarily inflamed. The inflammation is usually caused by cold viruses, so it often occurs together with other symptoms of a cold.Acute bronchitis causes a cough which might not go away for a while, even after the cold has gone away. Although the cough may be unpleasant and persistent, in otherwise healthy people it usually isn’t anything serious. The symptoms then go away on their own after a few weeks. Treatment with medication usually isn’t necessary. Some medications may help relieve the symptoms a bit.

Wikipedia : 76 Bronchitis is inflammation of the bronchi (large and medium-sized airways) in the lungs. Symptoms... more...

Sources

Related Diseases for Bronchitis

About this section

Diseases related to Bronchitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 314)
# Related Disease Score Top Affiliating Genes
1 bronchial disease 31.3 CCL11 CCR3 CXCL8 ELANE IL5 RNASE3
2 pulmonary disease, chronic obstructive 31.0 CCL11 CCR3 CFTR CRP CXCL8 ELANE
3 pulmonary emphysema 30.6 ELANE SERPINA1 SERPINB1
4 sinusitis 30.4 CFTR CXCL8 IL5 RNASE3
5 pneumoconiosis 30.4 CXCL8 SERPINA1 TNF
6 bronchiectasis 30.3 CFTR CXCL8 ELANE MPO SERPINA1
7 pneumonia 30.3 CCL11 CRP CXCL8 ELANE IL5 LACTB
8 rhinitis 30.1 CCL11 CXCL8 IL5 RNASE3 VIP
9 pollen allergy 30.1 IL5 MPO RNASE3
10 pulmonary eosinophilia 30.1 CCL11 IL5 RNASE3
11 asthma 30.0 CCL11 CCR3 CFTR CXCL8 ELANE IL5
12 allergic rhinitis 30.0 CCL11 CXCL8 IL5 MPO RNASE3 VIP
13 status asthmaticus 30.0 CXCL8 ELANE IL5 RNASE3
14 bronchiolitis 30.0 CCL11 CRP CXCL8 IL5 RNASE3 TNF
15 common cold 29.9 ALB CCL11 CXCL8 IL5 RNASE3
16 cystic fibrosis 29.9 CFTR CXCL8 ELANE MPO RNASE3 SERPINA1
17 aspergillosis 29.9 CFTR ELANE IL5 TNF
18 bacterial pneumonia 29.9 CRP CXCL8 ELANE LACTB
19 chronic eosinophilic pneumonia 29.8 CCL11 IL5 RNASE3
20 eosinophilic pneumonia 29.8 CCL11 IL5 RNASE3
21 acute respiratory distress syndrome 29.8 CXCL8 ELANE TNF
22 typhoid fever 29.8 ALB CFTR CRP TNF
23 acute cystitis 29.7 ALB CRP CXCL8
24 microscopic polyangiitis 29.7 MPO TNF
25 allergic asthma 29.7 CCL11 IL5 RNASE3
26 eosinophilic gastroenteritis 29.7 ALB CCL11 IL5 RNASE3
27 chlamydia 29.7 CRP CXCL8 TNF
28 ulcerative colitis 29.6 CRP CXCL8 MPO TNF
29 pyelonephritis 29.6 ALB CRP CXCL8 TNF
30 esophagitis 29.6 CCL11 CCR3 CXCL8 IL5
31 lung disease 29.4 CFTR CXCL8 ELANE IL5 MPO RNASE3
32 otitis media 29.4 ALB CCL11 CXCL8 LACTB RNASE3 TNF
33 appendicitis 29.4 ALB CRP CXCL8 MPO TNF
34 respiratory failure 29.3 ALB CRP CXCL8 ELANE SERPINA1 TNF
35 dermatitis, atopic 29.3 CCL11 CCR3 CXCL8 IL5 RNASE3 TNF
36 gastroenteritis 29.3 ALB CCL11 CRP CXCL8 IL5 LACTB
37 plastic bronchitis 12.6
38 lung cancer 11.3
39 chronic laryngitis 11.3
40 agammaglobulinemia, x-linked 11.0
41 ciliary dyskinesia, primary, 7 11.0
42 severe combined immunodeficiency 11.0
43 selective igm deficiency disease 11.0
44 pharyngoconjunctival fever 11.0
45 actinobacillosis 11.0
46 agammaglobulinemia, non-bruton type 11.0
47 parainfluenza virus type 3 11.0
48 tracheobronchomalacia 11.0
49 brown-vialetto-van laere syndrome 1 10.8
50 congenital laryngeal palsy 10.8

Comorbidity relations with Bronchitis via Phenotypic Disease Network (PDN): (show top 50) (show all 130)


Acquired Polycythemia Active Peptic Ulcer Disease
Acute Conjunctivitis Acute Cor Pulmonale
Acute Cystitis Acute Ethmoiditis
Acute Frontal Sinusitis Acute Kidney Failure
Acute Maxillary Sinusitis Agammaglobulinemia, X-Linked
Allergic Rhinitis Alzheimer Disease
Anthracosis Anxiety
Aortic Valve Disease 1 Asbestosis
Aspergillosis Asthma
Atrophic Gastritis Benign Essential Hypertension
Bronchiectasis Bronchopneumonia
Cardiac Arrest Cerebral Atherosclerosis
Cerebral Degeneration Cerebrovascular Disease
Chronic Ethmoiditis Chronic Frontal Sinusitis
Chronic Kidney Failure Chronic Laryngitis
Chronic Maxillary Sinusitis Chronic Myocardial Ischemia
Chronic Pulmonary Heart Disease Chronic Rhinitis
Conjunctivitis Conn's Syndrome
Cystitis Decubitus Ulcer
Deficiency Anemia Diabetic Polyneuropathy
Diaphragm Disease Duodenitis
Dyskinesia of Esophagus Dysthymic Disorder
Encephalopathy Esophageal Candidiasis
Esophageal Disease Esophagitis
Familial Atrial Fibrillation First-Degree Atrioventricular Block

Graphical network of the top 20 diseases related to Bronchitis:



Diseases related to Bronchitis
Sources

Symptoms & Phenotypes for Bronchitis

About this section

Symptoms:

12
  • • cough
  • • shortness of breath
  • • chest tightness
  • • low fever

UMLS symptoms related to Bronchitis:


fever, pruritus, recurrent pharyngitis, snoring, coughing

MGI Mouse Phenotypes related to Bronchitis:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 9.85 CCL11 CCR3 CFTR ELANE IL5 MPO
2 immune system MP:0005387 9.7 CCL11 CCR3 CFTR CRP ELANE IL5
3 respiratory system MP:0005388 9.17 CCL11 CCR3 CFTR IL5 SERPINB1 TNF
Sources

Drugs & Therapeutics for Bronchitis

About this section

PubMedHealth treatment related to Bronchitis: 63

Acute bronchitis gets better on its own without treatment. If you feel weak and ill, it’s best to take it easy for a few days. This also means not doing any sports or other strenuous physical activities. Hot tea or broth is usually considered to have a soothing effect. But there is no scientific proof that drinking a lot more fluids than usual helps, or doesn’t help.Acute bronchitis doesn’t need to be treated with medication. Drugs such as paracetamol (acetaminophen) or ibuprofen are sometimes a good idea, though, for the relief of cold symptoms such as fever and pain.There hasn’t been enough research on the effectiveness of cough medicines that are designed to make you cough less (cough suppressants) or make it easier to cough up phlegm (expectorants). Because coughing has the important function of getting rid of mucus and foreign objects, cough suppressants should only be used for a limited amount of time, and only for really unpleasant, dry coughs that disrupt your sleep. Herbal medicines might relieve coughs somewhat.Because the symptoms are usually caused by viruses, antibiotics don’t help much in the treatment of acute bronchitis. But they can have side effects and contribute to bacteria becoming resistant. So antibiotics aren’t recommended as a treatment for acute bronchitis.

FDA approved drugs:

(show all 6)
# Drug Name Active Ingredient(s) 18 Company Approval Date
1
Augmentin 18 AMOXICILLIN; CLAVULANATE POTASSIUM SmithKline Beecham February 1996
2
Avelox I.V. 18 MOXIFLOXACIN HYDROCHLORIDE Bayer November 2001
3
Biaxin XL 18 CLARITHROMYCIN Abbott Laboratories March 2000
4
Cedax 18 CEFTIBUTEN DIHYDRATE Schering-Plough December 1995
5
Ceftin 18 CEFUROXIME AXETIL GlaxoSmithKline September 1997
6
Tequin 18 Bristol-Myers Squibb December, 1999

Drugs for Bronchitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 386)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Terbutaline Approved Phase 4 23031-25-6 5403
2
Budesonide Approved Phase 4,Phase 2,Phase 1 51333-22-3 63006 5281004
3
Montelukast Approved Phase 4,Phase 3,Phase 2,Not Applicable 158966-92-8 5281040
4
Epinephrine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 51-43-4 5816
5
Bromhexine Approved Phase 4 3572-43-8
6
Racepinephrine Approved Phase 4,Phase 3,Phase 2,Not Applicable 329-65-7 838
7
Azithromycin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 83905-01-5 55185 447043
8
Levofloxacin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 100986-85-4 149096
9
Ofloxacin Approved Phase 4,Phase 3,Phase 2,Phase 1 82419-36-1 4583
10
Acetylcysteine Approved, Investigational Phase 4,Phase 2,Not Applicable 616-91-1 12035
11
Etanercept Approved, Investigational Phase 4,Phase 1,Phase 2 185243-69-0
12
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-02-2 5743
13
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 1177-87-3
14
Moxifloxacin Approved, Investigational Phase 4,Phase 3 354812-41-2, 151096-09-2 152946
15
Amoxicillin Approved, Vet_approved Phase 4,Phase 3 26787-78-0 33613
16 Estradiol valerate Approved, Investigational, Vet_approved Phase 4,Phase 3 979-32-8
17
Polyestradiol phosphate Approved Phase 4,Phase 3 28014-46-2
18
Norgestimate Approved, Investigational Phase 4,Phase 3 35189-28-7 6540478
19
Ethinyl Estradiol Approved Phase 4,Phase 3 57-63-6 5991
20
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 3 50-28-2 5757
21
Telithromycin Approved Phase 4 191114-48-4 0 5462516
22
Cefuroxime Approved Phase 4,Phase 3,Not Applicable 55268-75-2 5361202 5479529
23
Fluticasone Approved, Experimental Phase 4,Phase 3,Phase 2,Not Applicable 90566-53-3 62924
24
Guaifenesin Approved, Investigational, Vet_approved Phase 4,Phase 3 93-14-1 3516
25
Ephedrine Approved Phase 4,Phase 3,Phase 2,Not Applicable 299-42-3 9294
26
Pseudoephedrine Approved Phase 4,Phase 3,Phase 2,Not Applicable 90-82-4 7028
27
Clarithromycin Approved Phase 4,Phase 3 81103-11-9 84029
28
Erythromycin Approved, Investigational, Vet_approved Phase 4 114-07-8 12560
29
Doxycycline Approved, Investigational, Vet_approved Phase 4 564-25-0 54671203
30
Angiotensin II Approved, Investigational Phase 4,Not Applicable 11128-99-7, 68521-88-0, 4474-91-3 172198 65143
31
Losartan Approved Phase 4,Not Applicable 114798-26-4 3961
32
leucovorin Approved Phase 4,Phase 2,Phase 1 58-05-9 6006 143
33
Trimethoprim Approved, Vet_approved Phase 4 738-70-5 5578
34
Sulfamethoxazole Approved Phase 4 723-46-6 5329
35
Zinc Approved, Investigational Phase 4,Phase 3,Not Applicable 7440-66-6
36
Aztreonam Approved Phase 4 78110-38-0 5362041 5742832
37
Mechlorethamine Approved, Investigational Phase 4,Phase 2,Phase 3 51-75-2 4033
38
Methylprednisolone Approved, Vet_approved Phase 4,Not Applicable 83-43-2 6741
39
Prednisolone Approved, Vet_approved Phase 4,Not Applicable 50-24-8 5755
40
Prednisolone phosphate Approved, Vet_approved Phase 4,Not Applicable 302-25-0
41
Methylprednisolone hemisuccinate Approved Phase 4,Not Applicable 2921-57-5
42
Prednisone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 53-03-2 5865
43
Oseltamivir Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 204255-11-8, 196618-13-0 65028
44
Cefdinir Approved Phase 4 91832-40-5 6915944
45
Acetazolamide Approved, Vet_approved Phase 4 59-66-5 1986
46
Ibuprofen Approved Phase 4 15687-27-1 3672
47
Acetaminophen Approved Phase 4 103-90-2 1983
48
Ivacaftor Approved Phase 4,Phase 2 873054-44-5 16220172
49
Mannitol Approved, Investigational Phase 4 69-65-8 453 6251
50
Ergocalciferol Approved, Nutraceutical Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 50-14-6 5280793

Interventional clinical trials:

(show top 50) (show all 705)
# Name Status NCT ID Phase Drugs
1 The Effect of Bronchodilator on Eosinophilic Bronchitis and Cough Variant Asthma Unknown status NCT02002754 Phase 4 Bambuterol Hydrochloride tablets
2 Therapeutic Effect of Different Treatment Course With Inhaled Corticosteroids in Eosinophilic Bronchitis Patients Unknown status NCT02002715 Phase 4 Inhaled budesonide
3 Efficacy and Safety of add-on Montelukast to Inhaled Budesonide in the Treatment of Nonasthmatic Eosinophilic Bronchitis Unknown status NCT01121016 Phase 4 Montelukast
4 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Roflumilast on Endothelial Function in Patients With Chronic Obstructive Pulmonary Disease Unknown status NCT01595750 Phase 4 Roflumilast 500;Placebo
5 Effects of Exercise Training on Systemic Inflammation an Muscle Repair According to the Obstructive Chronic Pulmonary Disease (COPD) Phenotype Unknown status NCT01431625 Phase 4
6 Use of Roflumilast to Prevent Exacerbations in Fibrotic Sarcoidosis Patients (REFS) Unknown status NCT01830959 Phase 4 Roflumilast;Placebo
7 Sunovion Brovana Versus Serevent Inspiratory Capacity High Resolution Computed Tomography Unknown status NCT01361984 Phase 4 Nebulized arformoterol;Salmeterol
8 Small Airways Evaluation and Treatment Unknown status NCT02526758 Phase 4 beclomethasone;formoterol;budesonide
9 Optimizing Influenza Vaccination in Surgical Oncology Patients Unknown status NCT01698177 Phase 4
10 Effect of Vitamin D Supplementation in Young South African Children Hospitalized With Acute Lower Respiratory Infection Unknown status NCT02054182 Phase 4 Vitamin D
11 High Flow Nasal Cannula vs Low Flow Oxygen Therapy in Bronchiolitis Unknown status NCT03015051 Phase 4 Oxygen
12 Home Oxygen Therapy in Bronchiolitis Unknown status NCT01216553 Phase 4
13 Bronchiolitis All-study, SE-Norway Unknown status NCT00817466 Phase 4 Racemic adrenaline;Isotonic saline
14 Study Regarding the Clinical Efficacy of Synatura® in Patients With Chronic Bronchitis Type COPD Completed NCT03623282 Phase 4 Synatura® 15 mL
15 Moxifloxacin Versus Amoxicillin Clavulanic Acid in Treatment of Acute Exacerbation of Chronic Bronchitis Completed NCT00656747 Phase 4 Avelox (Moxifloxacin, BAY12-8039);Amoxicillin clavulanic acid
16 Mucolytic Effectiveness of Tacholiquine ® in Chronic Bronchitis Completed NCT02515799 Phase 4 Tacholiquine
17 The Effectiveness of Roflumilast in Improving Mucociliary Clearance in Patients With COPD and Chronic Bronchitis Completed NCT03073798 Phase 4 Roflumilast;Placebo
18 Telithromycin: in the Treatment of Acute Exacerbation of Chronic Bronchitis in Adult Outpatients With COPD Completed NCT00538148 Phase 4 Telithromycin
19 PERSPECTIVE: Telithromycin - Acute Exacerbation of Chronic Bronchitis Completed NCT00132938 Phase 4 telithromycin
20 Study of Azithromycin for Lymphocytic Bronchiolitis/Bronchitis After Lung Transplantation Completed NCT01109160 Phase 4 Azithromycin Dihydrate
21 Ceftidoren Versus Levofloxacin in the Treatment of Patients With Acute Exacerbations of Chronic Bronchitis (AECB) Completed NCT01467297 Phase 4 ceftidoren;levofloxacin
22 Ketek in CAP / AECB in Ambulatory Adult Patients Completed NCT00546676 Phase 4 Telithromycin
23 Airway Clearance for Prevention of Chronic Obstructive Pulmonary Disease (COPD) Exacerbation Completed NCT00181207 Phase 4
24 Efficacy Safety Study of Arformoterol/Tiotropium Combination Versus Either Therapy Alone in Chronic Obstructive Pulmonary Disease (COPD) Completed NCT00424528 Phase 4 Arformoterol Tartrate Inhalation Solution;Tiotropium;Arformoterol and Tiotropium;Placebo
25 Relative Potency of Inhaled Corticosteroids Completed NCT00292838 Phase 4 fluticasone 25, 50, 100, 200 mcg
26 Phase 4 Study - Mucinex D as Adjunct Therapy Completed NCT00441246 Phase 4 Mucinex D (600 mg guaifenesin and 60 mg pseudoephedrine HCl extended-release bi-layer tablets)
27 Effect of Addition Oral Montelukast to Standard Treatment in Acute Asthma in Hospitalized Preschool Children Completed NCT03369119 Phase 4 Montelukast 4 Mg Oral Granule;Placebos
28 Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization Study Completed NCT01110200 Phase 4 ADVAIR DISKUS 250/50 mg BID;SEREVENT 50 mcg BID
29 Add-on Effects of Tiotropium Over Formoterol in Exercise Tolerance on Chronic Obstructive Pulmonary Disease Patients Completed NCT00680056 Phase 4 Formoterol plus Placebo (Tiotropium);Formoterol plus Tiotropium
30 COPD on Primary Care Treatment (COOPT) Completed NCT00184977 Phase 4 N-acetylcysteine;fluticasone propionate
31 Aizthromycin or Clarithromycin in H-pylori Eradication Regimen Completed NCT01667692 Phase 4 azithromycin;clarithmycin
32 Inhaled Steroid Reduces Systemic Inflammation in COPD Completed NCT00175565 Phase 4 inhaled fluticasone 500 mcg b.i.d.
33 Clinical Trial for the Assessment of Delayed Antibiotic Treatment in Pediatric (DAP-Pediatrics) Completed NCT01800747 Phase 4
34 Roflumilast on Markers of Bone Metabolism and Endothelial Function in COPD Completed NCT01745848 Phase 4 Roflumilast
35 BENEFITS OF ACLIDINIUM BROMIDE IN THE RELIEF OF COPD SYMPTOMS INCLUDING COUGH Completed NCT02375724 Phase 4 Aclidinium Bromide;Placebo
36 Placebo Versus Antibiotics in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD) Completed NCT00170222 Phase 4 doxycycline
37 Study of Enbrel in Rheumatoid Arthritis (RA) Subjects With Comorbid Disorders Completed NCT00132418 Phase 4 Enbrel;Placebo
38 Efficacy of Losartan in Preventing Progression of COPD Completed NCT00720226 Phase 4 Losartan;Placebo
39 Change of Inspiratory Peak Flow in COPD Completed NCT00561886 Phase 4 Formoterol
40 Advair HFA For Chronic Obstructive Pulmonary Disease(COPD) Completed NCT00633217 Phase 4 Fluticasone Propionate/Salmeterol DISKUS 250/50mcg;Fluticasone Propionate/Salmeterol Hydrofluoroalkane 134a MDI 230/42mcg
41 Telithromycin in Respiratory Tract Infections Completed NCT00261105 Phase 4 telithromycin
42 A Clinical Trial to Evaluate the Efficacy and Safety of YMC026 in Respiratory Disease Patients Completed NCT03334916 Phase 4 YMC026;Placebo
43 Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Combinations of Long-acting β2-agonists (LABA) and Inhaled Glucocorticosteroid (ICS) Completed NCT01329029 Phase 4 Roflumilast;Placebo
44 Effect of Weight and/or Obesity on Sulfamethoxazole and Trimethoprim Concentrations Completed NCT01167452 Phase 4 Sulfamethoxazole/trimethoprim
45 Proteomic Profiling for Influenza Completed NCT00133588 Phase 4
46 Clinical Trial for the Assessment of Delayed Antibiotic Treatment Strategies Completed NCT01363531 Phase 4
47 Effectiveness of Different Exercise Training Programs to the Profile of COPD Patients Completed NCT01336283 Phase 4
48 Bacille Calmette Guérin Immunisation at Birth and Childhood Morbidity in Danish Children. Completed NCT01694108 Phase 4
49 An Investigation of the Mechanism of Action of Seretide in Chronic Obstructive Pulmonary Disease Completed NCT00974805 Phase 4 Seretide 500 Accuhaler
50 Efficacy of Temporary Positive Expiratory Pressure (TPEP) in Chronic Hypersecretion Completed NCT00700388 Phase 4

Search NIH Clinical Center for Bronchitis

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Cochrane evidence based reviews: bronchitis

Sources

Genetic Tests for Bronchitis

About this section

Genetic tests related to Bronchitis:

# Genetic test Affiliating Genes
1 Chronic Bronchitis 29
Sources

Anatomical Context for Bronchitis

About this section

MalaCards organs/tissues related to Bronchitis:

41
Lung, Testes, Skin, Heart, Kidney, Tonsil, Liver
Sources

Publications for Bronchitis

About this section

Articles related to Bronchitis:

(show top 50) (show all 2102)
# Title Authors Year
1
Chronic bronchitis: High prevalence in never smokers and underdiagnosis- A population-based study in Colombia. ( 29669432 )
2019
2
Improved quality of life associated with long-term use of guaifenesin in a patient with chronic obstructive pulmonary disease (COPD) & stable chronic bronchitis: A case report. ( 30450278 )
2019
3
Mechanisms of bergenin treatment on chronic bronchitis analyzed by liquid chromatography-tandem mass spectrometry based on metabolomics. ( 30551484 )
2019
4
Efficacy and safety of GHX02 in the treatment of acute bronchitis: protocol of a phase II, double-blind, randomised placebo-controlled trial. ( 29764875 )
2018
5
Innate antiviral immune response against infectious bronchitis virus and involvement of prostaglandin E2 in the uterine mucosa of laying hens. ( 29407895 )
2018
6
Successful Treatment of Protein-Losing Enteropathy and Plastic Bronchitis by Biphasic Cuirass Ventilation in a Patient with Failing Fontan Circulation. ( 29794380 )
2018
7
Acute phase proteins and stress markers in the immediate response to a combined vaccination against Newcastle disease and infectious bronchitis viruses in specific pathogen free (SPF) layer chicks. ( 29182756 )
2018
8
Exposure to traffic-related air pollution and acute bronchitis in children: season and age as modifiers. ( 29440305 )
2018
9
Perception and Awareness of chronic obstructive pulmonary disease, Chronic Bronchitis and Pulmonary Emphysema in the Spanish Urban Population. ( 29428681 )
2018
10
Non-astmatic Eosinophilic Bronchitis. ( 29404185 )
2018
11
An underestimated cause of chronic cough: The Protracted Bacterial Bronchitis. ( 29387250 )
2018
12
Induction of innate host responses characterized by production of interleukin (IL)-1I^ and recruitment of macrophages to the respiratory tract of chickens following infection with infectious bronchitis virus (IBV). ( 29426399 )
2018
13
Plastic bronchitis associated with adenovirus infection. ( 29582774 )
2018
14
Viral interference between low pathogenic avian influenza H9N2 and avian infectious bronchitis viruses in vitro and in ovo. ( 29940196 )
2018
15
Echocardiographic characteristics in Fontan patients before the onset of protein-losing enteropathy or plastic bronchitis. ( 29082544 )
2018
16
In with acute bronchitis; out with duodenal perforation: the potentially harmful cascade of over-testing. A case report. ( 29441163 )
2018
17
Inappropriate Antibiotic Prescribing for Acute Bronchitis in Children and Impact on Subsequent Episodes of Care and Treatment. ( 29794648 )
2018
18
Induction of innate immune response following introduction of infectious bronchitis virus (IBV) in the trachea and renal tissues of chickens. ( 29330060 )
2018
19
Seroprevalence and genotyping of avian infectious bronchitis virus detected from Iranian unvaccinated backyard chickens. ( 29922421 )
2018
20
Using Multinomial and Space-Time Permutation Models to Understand the Epidemiology of Infectious Bronchitis in California Between 2008 and 2012. ( 29944405 )
2018
21
Rapid development and evaluation of a live-attenuated QX-like infectious bronchitis virus vaccine. ( 29891352 )
2018
22
An adult case of plastic bronchitis: a rare and multifactorial disease. ( 29600096 )
2018
23
Infectious bronchitis virus gel vaccination: evaluation of Mass-like (B-48) and 793/B-like (1/96) vaccine kinetics after combined administration at 1 day of age. ( 29897603 )
2018
24
Exposure to cooking oil fumes and chronic bronchitis in nonsmoking women aged 40A years and over: a health-care based study. ( 29439699 )
2018
25
Protection against Virulent Infectious Bronchitis Virus Challenge Conferred by a Recombinant Baculovirus Co-Expressing S1 and N Proteins. ( 29954092 )
2018
26
Recombinant live attenuated avian coronavirus vaccines with deletions in the accessory genes 3ab and/or 5ab protect against infectious bronchitis in chickens. ( 29366709 )
2018
27
Ambient Air Pollution and Chronic Bronchitis in a Cohort of U.S. Women. ( 29410384 )
2018
28
The ADRP domain from a virulent strain of infectious bronchitis virus is not sufficient to confer a pathogenic phenotype to the attenuated Beaudette strain. ( 29893665 )
2018
29
Gastroesophageal reflux symptoms and nasal symptoms affect the severity of bronchitis symptoms in patients with chronic obstructive pulmonary disease. ( 29773294 )
2018
30
Differential innate immune responses induced by classical and variant infectious bronchitis viruses in specific pathogen free chicks. ( 29751011 )
2018
31
Clinical Outcome of Eosinophilic Airway Inflammation in Chronic Airway Diseases Including Nonasthmatic Eosinophilic Bronchitis. ( 29317659 )
2018
32
Identification of Novel Linear Epitopes Located in the Infectious Bronchitis Virus Spike S2 Region. ( 29944406 )
2018
33
Obstructive bronchitis and recurrent pneumonia in esophageal achalasia in a child: A CARE compliant case report. ( 29879065 )
2018
34
Mitochondrial bioenergy alterations in avian HD11 macrophages infected with infectious bronchitis virus. ( 29302792 )
2018
35
Evaluation of an incidental cardiac finding in a patient with bronchitis. ( 29934369 )
2018
36
Alternative definitions of chronic bronchitis and their correlation with CT parameters. ( 29942122 )
2018
37
Molecular characteristic and pathogenicity analysis of a virulent recombinant avain infectious bronchitis virus isolated in China. ( 29917155 )
2018
38
The clinical, immunological and microbiological impact of the 10-valent pneumococcal-Protein D conjugate vaccine in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: a multi-centre, double-blind, randomised controlled trial. ( 29944440 )
2018
39
Preparation and protective efficacy of a chicken embryo kidney cell-attenuation GI-19/QX-like avian infectious bronchitis virus vaccine. ( 29859801 )
2018
40
Coexistence of Chronic Bronchitis in Chronic Obstructive Lung Disease. ( 29752708 )
2018
41
Excess of children's outpatient consultations due to asthma and bronchitis and the association between meteorological variables in Canoas City, Southern Brazil. ( 30499030 )
2018
42
Parental nicotine replacement therapy and offspring bronchitis/bronchiolitis and asthma - a nationwide population-based cohort study. ( 30310327 )
2018
43
Retrospectively reported childhood adversity is associated with asthma and chronic bronchitis, independent of mental health. ( 30314579 )
2018
44
Chronic Asthma and Bronchitis without Persistent Airflow Limitation May Have Been Misclassified as Chronic Obstructive Pulmonary Disease Using Administrative Data. ( 30216740 )
2018
45
Prevalence of avian influenza, Newcastle disease, and infectious bronchitis viruses in broiler flocks infected with multifactorial respiratory diseases in Iran, 2015-2016. ( 30377950 )
2018
46
Enhanced pathogenicity of low-pathogenic H9N2 avian influenza virus after vaccination with infectious bronchitis live attenuated vaccine. ( 30147269 )
2018
47
Detection of Newcastle Disease, H9N2 Avian Influenza, and Infectious Bronchitis Viruses in Respiratory Diseases in Backyard Chickens in Ahvaz, Iran, in 2014-2015. ( 30256035 )
2018
48
Airway cells from protracted bacterial bronchitis and bronchiectasis share similar gene expression profiles. ( 29575797 )
2018
49
Bronchiectasis, Chronic Suppurative Lung Disease and Protracted Bacterial Bronchitis. ( 29602647 )
2018
50
Impact of erdosteine on chronic bronchitis and COPD: A meta-analysis. ( 29233650 )
2018